المؤلفون: Farahmand P; School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Gyuraszova K; School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Rooney C; School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.; Department of Respiratory Medicine, Royal Infirmary, Glasgow, United Kingdom., Raffo-Iraolagoitia XL; CRUK Beatson Institute, Garscube Estate, Glasgow, United Kingdom., Jayasekera G; Glasgow Pleural Disease Unit, Queen Elizabeth University Hospital, Glasgow, United Kingdom., Hedley A; CRUK Beatson Institute, Garscube Estate, Glasgow, United Kingdom., Johnson E; CRUK Beatson Institute, Garscube Estate, Glasgow, United Kingdom., Chernova T; MRC Toxicology Unit, University of Cambridge, Cambridge, United Kingdom., Malviya G; CRUK Beatson Institute, Garscube Estate, Glasgow, United Kingdom., Hall H; CRUK Beatson Institute, Garscube Estate, Glasgow, United Kingdom., Monteverde T; School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Blyth K; School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.; CRUK Beatson Institute, Garscube Estate, Glasgow, United Kingdom.; Glasgow Pleural Disease Unit, Queen Elizabeth University Hospital, Glasgow, United Kingdom., Duffin R; Centre for Inflammation Research, Edinburgh, United Kingdom., Carlin LM; School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.; CRUK Beatson Institute, Garscube Estate, Glasgow, United Kingdom., Lewis D; School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.; CRUK Beatson Institute, Garscube Estate, Glasgow, United Kingdom., Le Quesne J; School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.; CRUK Beatson Institute, Garscube Estate, Glasgow, United Kingdom.; Department of Histopathology, Queen Elizabeth University Hospital, Glasgow, United Kingdom., MacFarlane M; MRC Toxicology Unit, University of Cambridge, Cambridge, United Kingdom., Murphy DJ; School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.; CRUK Beatson Institute, Garscube Estate, Glasgow, United Kingdom.

المصدر: Frontiers in toxicology [Front Toxicol] 2023 Jun 27; Vol. 5, pp. 1200650. Date of Electronic Publication: 2023 Jun 27 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101777990 Publication Model: eCollection Cited Medium: Internet ISSN: 2673-3080 (Electronic) Linking ISSN: 26733080 NLM ISO Abbreviation: Front Toxicol Subsets: PubMed not MEDLINE

المؤلفون: Secchiari F; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biología y Medicina Experimental (IBYME-CONICET), Argentina., Nuñez SY; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biología y Medicina Experimental (IBYME-CONICET), Argentina., Sierra JM; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biología y Medicina Experimental (IBYME-CONICET), Argentina., Ziblat A; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biología y Medicina Experimental (IBYME-CONICET), Argentina., Regge MV; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biología y Medicina Experimental (IBYME-CONICET), Argentina., Raffo Iraolagoitia XL; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biología y Medicina Experimental (IBYME-CONICET), Argentina., Rovegno A; Servicio de Urología, Centro de Educación Médica e Investigaciones Clínicas 'Norberto Quirno' (CEMIC)., Ameri C; Servicio de Urología, Hospital Alemán, Buenos Aires, Argentina., Secin FP; Servicio de Urología, Centro de Educación Médica e Investigaciones Clínicas 'Norberto Quirno' (CEMIC)., Richards N; Servicio de Urología, Centro de Educación Médica e Investigaciones Clínicas 'Norberto Quirno' (CEMIC)., Ríos Pita H; Servicio de Urología, Hospital Alemán, Buenos Aires, Argentina., Vitagliano G; Servicio de Urología, Hospital Alemán, Buenos Aires, Argentina., Rico L; Servicio de Urología, Hospital Alemán, Buenos Aires, Argentina., Mieggi M; Servicio de Urología, Hospital Alemán, Buenos Aires, Argentina., Frascheri F; Servicio de Urología, Hospital Alemán, Buenos Aires, Argentina., Bonanno N; Servicio de Urología, Hospital Alemán, Buenos Aires, Argentina., Blas L; Servicio de Urología, Hospital Alemán, Buenos Aires, Argentina., Trotta A; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biología y Medicina Experimental (IBYME-CONICET), Argentina., Friedrich AD; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biología y Medicina Experimental (IBYME-CONICET), Argentina., Fuertes MB; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biología y Medicina Experimental (IBYME-CONICET), Argentina., Domaica CI; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biología y Medicina Experimental (IBYME-CONICET), Argentina., Zwirner NW; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biología y Medicina Experimental (IBYME-CONICET), Argentina.; Facultad de Ciencias Exactas y Naturales, Departamento de Química Biológica, Universidad de Buenos Aires, Argentina.

المصدر: Oncoimmunology [Oncoimmunology] 2022 Aug 03; Vol. 11 (1), pp. 2104991. Date of Electronic Publication: 2022 Aug 03 (Print Publication: 2022).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Renal Cell*/therapy , Kidney Neoplasms*/therapy, Histocompatibility Antigens Class I/metabolism ; Humans ; NK Cell Lectin-Like Receptor Subfamily K/metabolism ; Receptors, Natural Killer Cell

المؤلفون: Leslie J; Newcastle Fibrosis Research Group, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.; The Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK., Mackey JBG; Cancer Research UK Beatson Institute, Glasgow, UK., Jamieson T; Cancer Research UK Beatson Institute, Glasgow, UK., Ramon-Gil E; Newcastle Fibrosis Research Group, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.; The Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK., Drake TM; Cancer Research UK Beatson Institute, Glasgow, UK.; MRC Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Fercoq F; Cancer Research UK Beatson Institute, Glasgow, UK., Clark W; Cancer Research UK Beatson Institute, Glasgow, UK., Gilroy K; Cancer Research UK Beatson Institute, Glasgow, UK., Hedley A; Cancer Research UK Beatson Institute, Glasgow, UK., Nixon C; Cancer Research UK Beatson Institute, Glasgow, UK., Luli S; Newcastle Fibrosis Research Group, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.; The Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK.; Preclinical In Vivo Imaging Facility, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Laszczewska M; Newcastle Fibrosis Research Group, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.; The Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK., Pinyol R; Translational Research in Hepatic Oncology, Liver Unit, IDIBAPS, Hospital Clínic, University of Barcelona, Barcelona, Spain., Esteban-Fabró R; Translational Research in Hepatic Oncology, Liver Unit, IDIBAPS, Hospital Clínic, University of Barcelona, Barcelona, Spain.; Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Willoughby CE; Translational Research in Hepatic Oncology, Liver Unit, IDIBAPS, Hospital Clínic, University of Barcelona, Barcelona, Spain., Haber PK; Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Andreu-Oller C; Translational Research in Hepatic Oncology, Liver Unit, IDIBAPS, Hospital Clínic, University of Barcelona, Barcelona, Spain.; Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Rahbari M; Division of Chronic Inflammation and Cancer, German Cancer Research Centre, Heidelberg, Germany., Fan C; Division of Chronic Inflammation and Cancer, German Cancer Research Centre, Heidelberg, Germany., Pfister D; Division of Chronic Inflammation and Cancer, German Cancer Research Centre, Heidelberg, Germany., Raman S; Department of Pathology, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK., Wilson N; Newcastle Fibrosis Research Group, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.; The Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK., Müller M; Cancer Research UK Beatson Institute, Glasgow, UK., Collins A; Newcastle Fibrosis Research Group, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.; The Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK., Geh D; Newcastle Fibrosis Research Group, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.; The Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK., Fuller A; Flow Cytometry Facility, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK., McDonald D; Flow Cytometry Facility, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK., Hulme G; Flow Cytometry Facility, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK., Filby A; Flow Cytometry Facility, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.; Innovation, Methodology and Innovation (IMA) theme, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Cortes-Lavaud X; Cancer Research UK Beatson Institute, Glasgow, UK., Mohamed NE; Cancer Research UK Beatson Institute, Glasgow, UK., Ford CA; Cancer Research UK Beatson Institute, Glasgow, UK., Raffo Iraolagoitia XL; Cancer Research UK Beatson Institute, Glasgow, UK., McFarlane AJ; Cancer Research UK Beatson Institute, Glasgow, UK., McCain MV; The Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK., Ridgway RA; Cancer Research UK Beatson Institute, Glasgow, UK., Roberts EW; Cancer Research UK Beatson Institute, Glasgow, UK., Barry ST; Bioscience, Early Oncology, AstraZeneca, Macclesfield, UK., Graham GJ; Chemokine Research Group, Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK., Heikenwälder M; Division of Chronic Inflammation and Cancer, German Cancer Research Centre, Heidelberg, Germany.; Department of Surgery, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany., Reeves HL; The Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK.; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Llovet JM; Translational Research in Hepatic Oncology, Liver Unit, IDIBAPS, Hospital Clínic, University of Barcelona, Barcelona, Spain.; Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain., Carlin LM; Cancer Research UK Beatson Institute, Glasgow, UK.; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Bird TG; Cancer Research UK Beatson Institute, Glasgow, UK.; MRC Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK., Sansom OJ; Cancer Research UK Beatson Institute, Glasgow, UK.; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.; Beatson Institute for Cancer Research, Glasgow, UK., Mann DA; Newcastle Fibrosis Research Group, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK derek.mann@newcastle.ac.uk.; The Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK.; Fibrofind Ltd, William Leech Building, Medical School, Newcastle University, Newcastle upon Tyne, UK.; Department of Gastroenterology and Hepatology, School of Medicine, Koç University, Istanbul, Turkey.

المصدر: Gut [Gut] 2022 Apr 27. Date of Electronic Publication: 2022 Apr 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: British Medical Assn Country of Publication: England NLM ID: 2985108R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3288 (Electronic) Linking ISSN: 00175749 NLM ISO Abbreviation: Gut Subsets: MEDLINE

المؤلفون: Plant T; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom., Eamsamarng S; Department of Infection, Immunity and Cardiovascular Disease and.; Bateson Centre, University of Sheffield, Sheffield, United Kingdom., Sanchez-Garcia MA; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom., Reyes L; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom., Renshaw SA; Department of Infection, Immunity and Cardiovascular Disease and.; Bateson Centre, University of Sheffield, Sheffield, United Kingdom., Coelho P; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom., Mirchandani AS; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom., Morgan JM; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom., Ellett FE; Department of Infection, Immunity and Cardiovascular Disease and.; Bateson Centre, University of Sheffield, Sheffield, United Kingdom.; BioMEMS Resource Centre, Division of Surgery, Innovation and Bioengineering, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Burn Care, Shriners Hospitals for Children - Boston, Boston, Massachusetts, USA., Morrison T; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom., Humphries D; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom., Watts ER; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom., Murphy F; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom., Raffo-Iraolagoitia XL; Cancer Research UK Beatson Institute, Glasgow, United Kingdom., Zhang A; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom., Cash JL; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom., Loynes C; Department of Infection, Immunity and Cardiovascular Disease and.; Bateson Centre, University of Sheffield, Sheffield, United Kingdom., Elks PM; Department of Infection, Immunity and Cardiovascular Disease and.; Bateson Centre, University of Sheffield, Sheffield, United Kingdom., Van Eeden F; Department of Infection, Immunity and Cardiovascular Disease and.; Department of Biomedical Science, University of Sheffield, Sheffield, United Kingdom., Carlin LM; Cancer Research UK Beatson Institute, Glasgow, United Kingdom.; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Furley AJ; Bateson Centre, University of Sheffield, Sheffield, United Kingdom.; Department of Biomedical Science, University of Sheffield, Sheffield, United Kingdom., Whyte MK; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease and., Walmsley SR; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease and.

المصدر: The Journal of clinical investigation [J Clin Invest] 2020 Jun 01; Vol. 130 (6), pp. 3221-3237.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE

مواضيع طبية MeSH: Cell Movement/*immunology , Membrane Proteins/*immunology , Nerve Tissue Proteins/*immunology , Neutrophils/*immunology , Signal Transduction/*immunology , Zebrafish/*immunology , Zebrafish Proteins/*immunology, Animals ; Humans ; Inflammation/immunology ; Inflammation/pathology ; Mice ; Neutrophils/pathology ; Up-Regulation/immunology

المؤلفون: Torres N; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biologia y Medicina Experimental, Buenos Aires, Argentina., Regge MV; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biologia y Medicina Experimental, Buenos Aires, Argentina., Secchiari F; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biologia y Medicina Experimental, Buenos Aires, Argentina., Friedrich AD; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biologia y Medicina Experimental, Buenos Aires, Argentina., Spallanzani RG; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biologia y Medicina Experimental, Buenos Aires, Argentina., Raffo Iraolagoitia XL; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biologia y Medicina Experimental, Buenos Aires, Argentina., Núñez SY; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biologia y Medicina Experimental, Buenos Aires, Argentina., Sierra JM; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biologia y Medicina Experimental, Buenos Aires, Argentina., Ziblat A; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biologia y Medicina Experimental, Buenos Aires, Argentina., Santilli MC; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biologia y Medicina Experimental, Buenos Aires, Argentina., Gilio N; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biologia y Medicina Experimental, Buenos Aires, Argentina., Almada E; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biologia y Medicina Experimental, Buenos Aires, Argentina., Lauche C; Inmunova, Buenos Aires, Argentina., Pardo R; Inmunova, Buenos Aires, Argentina., Domaica CI; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biologia y Medicina Experimental, Buenos Aires, Argentina., Fuertes MB; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biologia y Medicina Experimental, Buenos Aires, Argentina., Madauss KP; Trust in Science, Global Health R&D, GlaxoSmithKline, Collegeville, PA, United States., Hance KW; Oncology, GlaxoSmithKline, Collegeville, PA, United States., Gloger IS; Trust in Science, Global Health R&D, GlaxoSmithKline, Stevenage, United Kingdom., Zylberman V; Inmunova, Buenos Aires, Argentina., Goldbaum FA; Inmunova, Buenos Aires, Argentina.; Fundación Instituto Leloir, Instituto de Investigaciones Bioquímicas de Buenos Aires, Buenos Aires, Argentina., Zwirner NW; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biologia y Medicina Experimental, Buenos Aires, Argentina nzwirner@ibyme.conicet.gov.ar.; Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires, Argentina.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2020 Jun; Vol. 8 (1). Date of Electronic Publication: 2020 Jun 08.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*pharmacology , Antibody-Dependent Cell Cytotoxicity/*immunology , Histocompatibility Antigens Class I/*immunology , Lymphoma/*immunology , Recombinant Fusion Proteins/*immunology , Urinary Bladder Neoplasms/*immunology, Animals ; Brucella/enzymology ; Female ; Histocompatibility Antigens Class I/genetics ; Lymphoma/pathology ; Lymphoma/therapy ; Male ; Mice ; Mice, Inbred C57BL ; Multienzyme Complexes/genetics ; Multienzyme Complexes/immunology ; NK Cell Lectin-Like Receptor Subfamily K/genetics ; NK Cell Lectin-Like Receptor Subfamily K/immunology ; Tumor Cells, Cultured ; Urinary Bladder Neoplasms/pathology ; Urinary Bladder Neoplasms/therapy

المؤلفون: Nuñez SY; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biología y Medicina Experimental, C1428ADN Buenos Aires, Argentina; and., Ziblat A; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biología y Medicina Experimental, C1428ADN Buenos Aires, Argentina; and., Secchiari F; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biología y Medicina Experimental, C1428ADN Buenos Aires, Argentina; and., Torres NI; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biología y Medicina Experimental, C1428ADN Buenos Aires, Argentina; and., Sierra JM; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biología y Medicina Experimental, C1428ADN Buenos Aires, Argentina; and., Raffo Iraolagoitia XL; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biología y Medicina Experimental, C1428ADN Buenos Aires, Argentina; and., Araya RE; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biología y Medicina Experimental, C1428ADN Buenos Aires, Argentina; and., Domaica CI; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biología y Medicina Experimental, C1428ADN Buenos Aires, Argentina; and., Fuertes MB; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biología y Medicina Experimental, C1428ADN Buenos Aires, Argentina; and., Zwirner NW; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biología y Medicina Experimental, C1428ADN Buenos Aires, Argentina; and nzwirner@ibyme.conicet.gov.ar.; Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, C1428EGA Buenos Aires, Argentina.

المصدر: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2018 Feb 01; Vol. 200 (3), pp. 1008-1015. Date of Electronic Publication: 2017 Dec 27.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association of Immunologists Country of Publication: United States NLM ID: 2985117R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1550-6606 (Electronic) Linking ISSN: 00221767 NLM ISO Abbreviation: J Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Cell Communication/*immunology , Killer Cells, Natural/*immunology , Lymphocyte Activation/*immunology , Macrophage Activation/*immunology , Transforming Growth Factor beta/*metabolism, Antigens, CD/immunology ; CD56 Antigen/metabolism ; Cells, Cultured ; Coculture Techniques ; HLA-G Antigens/metabolism ; Humans ; Interferon-gamma/immunology ; Leukocyte Immunoglobulin-like Receptor B1/immunology ; Macrophages/immunology ; Transforming Growth Factor beta/immunology

المؤلفون: Ziblat A; Instituto de Biología y Medicina Experimental (IBYME-CONICET), Laboratorio de Fisiopatología de la Inmunidad Innata, Buenos Aires, Argentina., Nuñez SY; Instituto de Biología y Medicina Experimental (IBYME-CONICET), Laboratorio de Fisiopatología de la Inmunidad Innata, Buenos Aires, Argentina., Raffo Iraolagoitia XL; Instituto de Biología y Medicina Experimental (IBYME-CONICET), Laboratorio de Fisiopatología de la Inmunidad Innata, Buenos Aires, Argentina., Spallanzani RG; Instituto de Biología y Medicina Experimental (IBYME-CONICET), Laboratorio de Fisiopatología de la Inmunidad Innata, Buenos Aires, Argentina., Torres NI; Instituto de Biología y Medicina Experimental (IBYME-CONICET), Laboratorio de Fisiopatología de la Inmunidad Innata, Buenos Aires, Argentina., Sierra JM; Instituto de Biología y Medicina Experimental (IBYME-CONICET), Laboratorio de Fisiopatología de la Inmunidad Innata, Buenos Aires, Argentina., Secchiari F; Instituto de Biología y Medicina Experimental (IBYME-CONICET), Laboratorio de Fisiopatología de la Inmunidad Innata, Buenos Aires, Argentina., Domaica CI; Instituto de Biología y Medicina Experimental (IBYME-CONICET), Laboratorio de Fisiopatología de la Inmunidad Innata, Buenos Aires, Argentina., Fuertes MB; Instituto de Biología y Medicina Experimental (IBYME-CONICET), Laboratorio de Fisiopatología de la Inmunidad Innata, Buenos Aires, Argentina., Zwirner NW; Instituto de Biología y Medicina Experimental (IBYME-CONICET), Laboratorio de Fisiopatología de la Inmunidad Innata, Buenos Aires, Argentina.; Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires, Argentina.

المصدر: Frontiers in immunology [Front Immunol] 2018 Jan 17; Vol. 8, pp. 1959. Date of Electronic Publication: 2018 Jan 17 (Print Publication: 2017).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Print ISSN: 1664-3224 (Print) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: PubMed not MEDLINE

المؤلفون: Güttlein LN; Laboratorio de Terapia Molecular y Celular, IIBBA, Fundación Instituto Leloir, CONICET, Buenos Aires, Argentina., Benedetti LG; Laboratorio de Terapia Molecular y Celular, IIBBA, Fundación Instituto Leloir, CONICET, Buenos Aires, Argentina., Fresno C; Unidad Asociada: Área de Cs. Agrarias, Ingeniería, Cs. Biológicas y de la Salud. CONICET. Universidad Católica de Córdoba, Córdoba, Argentina., Spallanzani RG; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biología y Medicina Experimental-CONICET. Buenos Aires, Argentina., Mansilla SF; Laboratorio de Ciclo Celular y Estabilidad Genómica, IIBBA, Fundación Instituto Leloir, CONICET, Buenos Aires, Argentina., Rotondaro C; Laboratorio de Terapia Molecular y Celular, IIBBA, Fundación Instituto Leloir, CONICET, Buenos Aires, Argentina., Raffo Iraolagoitia XL; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biología y Medicina Experimental-CONICET. Buenos Aires, Argentina., Salvatierra E; Laboratorio de Terapia Molecular y Celular, IIBBA, Fundación Instituto Leloir, CONICET, Buenos Aires, Argentina., Bravo AI; Unidad de Inmunopatología, Hospital Interzonal General de Agudos Eva Perón, San Martín, Provincia de Buenos Aires, Argentina., Fernández EA; Unidad Asociada: Área de Cs. Agrarias, Ingeniería, Cs. Biológicas y de la Salud. CONICET. Universidad Católica de Córdoba, Córdoba, Argentina.; Facultad de Ciencias Exactas, Físicas y Naturales, Universidad Nacional de Córdoba, Córdoba, Argentina., Gottifredi V; Laboratorio de Ciclo Celular y Estabilidad Genómica, IIBBA, Fundación Instituto Leloir, CONICET, Buenos Aires, Argentina., Zwirner NW; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biología y Medicina Experimental-CONICET. Buenos Aires, Argentina.; Facultad de Ciencias Exactas y Naturales, Departamento de Química Biológica, Universidad de Buenos Aires, Buenos Aires, Argentina., Llera AS; Laboratorio de Terapia Molecular y Celular, IIBBA, Fundación Instituto Leloir, CONICET, Buenos Aires, Argentina., Podhajcer OL; Laboratorio de Terapia Molecular y Celular, IIBBA, Fundación Instituto Leloir, CONICET, Buenos Aires, Argentina. opodhajcer@leloir.org.ar.

المصدر: Molecular cancer research : MCR [Mol Cancer Res] 2017 Mar; Vol. 15 (3), pp. 304-316. Date of Electronic Publication: 2016 Dec 28.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101150042 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3125 (Electronic) Linking ISSN: 15417786 NLM ISO Abbreviation: Mol Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms/*metabolism , Breast Neoplasms/*pathology , Mammary Neoplasms, Experimental/*metabolism , Mammary Neoplasms, Experimental/*pathology , Osteonectin/*metabolism , Receptor, ErbB-2/*metabolism, Animals ; Breast Neoplasms/enzymology ; Breast Neoplasms/genetics ; Cell Growth Processes/physiology ; Cell Line, Tumor ; Female ; Humans ; MCF-7 Cells ; Mammary Neoplasms, Experimental/enzymology ; Mammary Neoplasms, Experimental/genetics ; Mice ; Mice, Inbred BALB C ; Neoplasm Metastasis ; Osteonectin/genetics ; Prognosis ; Receptor, ErbB-2/genetics ; Treatment Outcome

المؤلفون: Spallanzani RG; Laboratorio de Fisiopatología de la Inmunidad Innata, Instituto de Biología y Medicina Experimental (IBYME), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Vuelta de Obligado 2490, C1428ADN, Ciudad de Buenos Aires, Argentina., Dalotto-Moreno T, Raffo Iraolagoitia XL, Ziblat A, Domaica CI, Avila DE, Rossi LE, Fuertes MB, Battistone MA, Rabinovich GA, Salatino M, Zwirner NW

المصدر: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2013 Dec; Vol. 62 (12), pp. 1781-95. Date of Electronic Publication: 2013 Oct 11.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

مواضيع طبية MeSH: Antigens, Ly/*immunology , Breast Neoplasms/*immunology , CD11b Antigen/*immunology , Killer Cells, Natural/*immunology , Medroxyprogesterone Acetate/*pharmacology , Myeloid Cells/*immunology, Animals ; Antigens, Ly/metabolism ; Antineoplastic Agents, Hormonal/pharmacology ; Blotting, Western ; Breast Neoplasms/drug therapy ; Breast Neoplasms/pathology ; CD11b Antigen/metabolism ; Cell Differentiation ; Cell Proliferation ; Cytotoxicity, Immunologic ; Female ; Flow Cytometry ; Fluorescent Antibody Technique ; Humans ; Killer Cells, Natural/drug effects ; Killer Cells, Natural/metabolism ; Mice ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; Myeloid Cells/drug effects ; Myeloid Cells/metabolism ; Receptors, Glucocorticoid/metabolism ; STAT3 Transcription Factor/metabolism ; Tumor Cells, Cultured